The short version
Only one company currently supplies this market — there is no backup if it stumbles.
Market view
fostemsavir tromethamine · Powder
1 marketed package NDCs · 1 active manufacturer
Most dispensed: 600 mg · Tablet, Film Coated, Extended Release · #1 bottle/carton / 60 tablet, film coated, extended release in 1 bottle
What changed in the last 90 days
Every detected change for fostemsavir tromethamine, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
Common questions
- Is Fostemsavir tromethamine in shortage right now?
- No. FDA does not currently list Fostemsavir tromethamine in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Fostemsavir tromethamine?
- 2 companies have marketed Fostemsavir tromethamine in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
- What does Fostemsavir tromethamine cost?
- The typical pharmacy pays about $156.84 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.